Peripheral Artery Disease Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approval, IND, ROA, MOA, NDA Approval and Companies involved by DelveInsight

(Albany, United States) "Peripheral Artery Disease Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Peripheral Artery Disease Market.

As per DelveInsight's assessment, globally, Peripheral Artery Disease pipeline constitutes 20+ key companies continuously working towards developing 22+ Peripheral Artery Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Peripheral Artery Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Request for sample report @ https://www.delveinsight.com/report-store/peripheral-arterial-disease-pad-pulmonary-vascular-disease-pvd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key takeaways from the Peripheral Artery Disease Pipeline Report:
• Peripheral Artery Disease Companies across the globe are diligently working toward developing novel Peripheral Artery Disease treatment therapies with a considerable amount of success over the years.
• Peripheral Artery Disease companies working in the treatment market are Ixaka Ltd (formerly known as Rexgenero), Hemostemix Inc., Caladrius Biosciences, Humacyte, Inc., Novo Nordisk, Helixmith, and others, are developing therapies for the Peripheral Artery Disease treatment
• Emerging Peripheral Artery Disease therapies in the different phases of clinical trials are- REX-001, ACP-01, Honedra, Human Acellular Vessel (HAV), Semaglutide, VM202, and others are expected to have a significant impact on the Peripheral Artery Disease market in the coming years.
• In June 2024, The U.S. Food and Drug Administration (FDA) has granted Amplitude Vascular Systems (AVS) an investigational device exemption (IDE), allowing the company to proceed with a pivotal trial for its pulsatile intravascular lithotripsy therapy. The POWER-PAD-II clinical study will assess the safety and effectiveness of AVS's Pulse IVL System in treating patients with severely calcified peripheral arterial disease.
• In November 2024, R3 Vascular, a U.S.-based bioabsorbable scaffold company, has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the ELITE-BTK pivotal trial for its peripheral arterial disease (PAD) treatment.
• In March 2024, BD (Becton, Dickinson and Company) (NYSE: BDX), a prominent global medical technology firm, announced today the enrollment of the first patient in the investigational device exemption (IDE) study titled "AGILITY." This study aims to evaluate the safety and effectiveness of the BD Vascular Covered Stent in treating Peripheral Arterial Disease (PAD).
• In February 2024, Sensome has initiated the SEPARATE clinical trial to assess its Clotild Smart Guidewire technology for detecting blood vessel blockages in patients with peripheral artery disease (PAD). The Clotild device, which received breakthrough designation from the US Food and Drug Administration (FDA) in 2021 for brain artery applications, is now being evaluated for its potential benefits in PAD treatment.

Peripheral Artery Disease Overview
Peripheral Artery Disease (PAD) is a common circulatory condition in which Peripheral Artery Disease causes narrowed arteries, reducing blood flow to the limbs, especially the legs. Peripheral Artery Disease symptoms typically include leg pain when walking, numbness, and weakness. If left untreated, Peripheral Artery Disease complications can lead to ulcers, infections, or even limb amputation.
Peripheral Artery Disease diagnosis involves physical exams, ankle-brachial index (ABI), and imaging tests to assess blood flow. Peripheral Artery Disease treatment aims to manage symptoms and prevent progression. Peripheral Artery Disease medications like antiplatelets, cholesterol-lowering drugs, and blood pressure control are commonly prescribed
For many, Peripheral Artery Disease lifestyle changes-such as quitting smoking, exercising regularly, and adopting a heart-healthy diet-can significantly improve outcomes. In advanced cases, Peripheral Artery Disease surgery or angioplasty may be needed to restore proper blood flow.
Early Peripheral Artery Disease detection is critical for preventing serious health risks such as heart attack or stroke. Understanding Peripheral Artery Disease risk factors, including diabetes, smoking, high cholesterol, and aging, is essential for prevention.
With timely Peripheral Artery Disease management, individuals can lead active, healthy lives while minimizing the impact of the disease.

Get a Free Sample PDF Report to know more about Peripheral Artery Disease Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/peripheral-arterial-disease-pad-pulmonary-vascular-disease-pvd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Emerging Peripheral Artery Disease Drugs Under Different Phases of Clinical Development Include:
• REX-001: Ixaka Ltd (formerly known as Rexgenero)
• ACP-01: Hemostemix Inc.
• Honedra: Caladrius Biosciences
• Human Acellular Vessel (HAV): Humacyte, Inc.
• Semaglutide: Novo Nordisk
• VM202: Helixmith

Peripheral Artery Disease Route of Administration
Peripheral Artery Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Peripheral Artery Disease Molecule Type
Peripheral Artery Disease Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Peripheral Artery Disease Pipeline Therapeutics Assessment
• Peripheral Artery Disease Assessment by Product Type
• Peripheral Artery Disease By Stage and Product Type
• Peripheral Artery Disease Assessment by Route of Administration
• Peripheral Artery Disease By Stage and Route of Administration
• Peripheral Artery Disease Assessment by Molecule Type
• Peripheral Artery Disease by Stage and Molecule Type

DelveInsight's Peripheral Artery Disease Report covers around 22+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Peripheral Artery Disease product details are provided in the report. Download the Peripheral Artery Disease pipeline report to learn more about the emerging Peripheral Artery Disease therapies - https://www.delveinsight.com/report-store/peripheral-arterial-disease-pad-pulmonary-vascular-disease-pvd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr


Some of the key companies in the Peripheral Artery Disease Therapeutics Market include:
Key companies developing therapies for Peripheral Artery Disease are - BIOTRONIK, Cardinal Health, Terumo Corporation, Bayer AG, Abbott, Boston Scientific Corporation, AngioDynamics, Koninklijke Philips NV, Cook, Medtronic, Cardinal Health, B. Braun Melsungen AG, and others.

Peripheral Artery Disease Pipeline Analysis:
The Peripheral Artery Disease pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Peripheral Artery Disease with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Peripheral Artery Disease Treatment.
• Peripheral Artery Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Peripheral Artery Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Peripheral Artery Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Peripheral Artery Disease drugs and therapies - https://www.delveinsight.com/sample-request/peripheral-arterial-disease-pad-pulmonary-vascular-disease-pvd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Peripheral Artery Disease Pipeline Market Drivers
Increasing Prevalence of PAD, Technological Advancements, Growing Awareness, Government Initiatives, Improved Healthcare Infrastructure, Rising Healthcare Expenditure, Collaboration and Partnerships, Aging Population, are some of the important factors that are fueling the Peripheral Artery Disease Market.

Peripheral Artery Disease Pipeline Market Barriers
However, High Treatment Costs, Limited Awareness in Developing Regions, Regulatory Challenges, Economic Instability, Clinical Trial Challenges, Healthcare Infrastructure Gaps, and other factors are creating obstacles in the Peripheral Artery Disease Market growth.

Scope of Peripheral Artery Disease Pipeline Drug Insight
• Coverage: Global
• Key Peripheral Artery Disease Companies: Ixaka Ltd (formerly known as Rexgenero), Hemostemix Inc., Caladrius Biosciences, Humacyte, Inc., Novo Nordisk, Helixmith, and others
• Key Peripheral Artery Disease Therapies: REX-001, ACP-01, Honedra, Human Acellular Vessel (HAV), Semaglutide, VM202, and others
• Peripheral Artery Disease Therapeutic Assessment: Peripheral Artery Disease current marketed and Peripheral Artery Disease emerging therapies
• Peripheral Artery Disease Market Dynamics: Peripheral Artery Disease market drivers and Peripheral Artery Disease market barriers

Request for Sample PDF Report for Peripheral Artery Disease Pipeline Assessment and clinical trials - https://www.delveinsight.com/sample-request/peripheral-arterial-disease-pad-pulmonary-vascular-disease-pvd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Peripheral Artery Disease Report Introduction
2. Peripheral Artery Disease Executive Summary
3. Peripheral Artery Disease Overview
4. Peripheral Artery Disease- Analytical Perspective In-depth Commercial Assessment
5. Peripheral Artery Disease Pipeline Therapeutics
6. Peripheral Artery Disease Late Stage Products (Phase II/III)
7. Peripheral Artery Disease Mid Stage Products (Phase II)
8. Peripheral Artery Disease Early Stage Products (Phase I)
9. Peripheral Artery Disease Preclinical Stage Products
10. Peripheral Artery Disease Therapeutics Assessment
11. Peripheral Artery Disease Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Peripheral Artery Disease Key Companies
14. Peripheral Artery Disease Key Products
15. Peripheral Artery Disease Unmet Needs
16 . Peripheral Artery Disease Market Drivers and Barriers
17. Peripheral Artery Disease Future Perspectives and Conclusion
18. Peripheral Artery Disease Analyst Views
19. Appendix
20. About DelveInsight

Trending Reports:
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast
• Acquired Immunodeficiency Syndrome Market: https://www.delveinsight.com/report-store/acquired-immunodeficiency-syndrome-aids-market
• Actinic Keratosis Market: https://www.delveinsight.com/infographics/actinic-keratosis-market
• Acute Intermittent Porphyria Market: https://www.delveinsight.com/report-store/acute-intermittent-porphyria-market
• Ashermans Syndrome Market: https://www.delveinsight.com/report-store/ashermans-syndrome-market
• Bacterial Skin Diseases Market: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Biliary Stents Market: https://www.delveinsight.com/report-store/biliary-stents-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Bone Densitometers Market: https://www.delveinsight.com/blog/bone-densitometers-market-analysis
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-release-system-market
• Diabetic Neuropathy Market: https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Exocrine Pancreatic Insufficiency Market: https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
• Head And Neck Squamous Cell Carcinoma Market: https://www.delveinsight.com/report-store/head-and-neck-cancer-hnc-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Pharma Competitive Intelligence: https://www.delveinsight.com/blog/competitive-intelligence-in-healthcare-sector
• Precocious Puberty Market: https://www.delveinsight.com/report-store/precocious-puberty-market
• Walking Impairment In Multiple Sclerosis Market: https://www.delveinsight.com/report-store/walking-impairment-in-multiple-sclerosis-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Biochips Market: https://www.delveinsight.com/blog/biochips-market-landscape
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Contraceptive Devices Market: https://www.delveinsight.com/report-store/contraceptive-devices-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/infographics/diabetic-foot-ulcers-dfus-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Wound Closure Devices Market: https://www.delveinsight.com/report-store/wound-closure-device-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-atrt-epidemiology-forecast
• Bladder Cancer Market: https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-epidemiology-forecast
• Global Electrophysiology Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Pharma Licensing Services: https://www.delveinsight.com/consulting/licensing-services
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Radioligand Therapies Market: https://www.delveinsight.com/report-store/radioligand-therapies-market-forecast
• Continuous Renal Replacement Therapy Machines Market: https://www.delveinsight.com/report-store/continuous-renal-replacement-therapy-machines-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market-forecast
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-pipeline-insight
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Astigmatism Market: https://www.delveinsight.com/report-store/astigmatism-market
• Calcinosis Cutis Market: https://www.delveinsight.com/report-store/calcinosis-cutis-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market
• Molecular Glue Market: https://www.delveinsight.com/report-store/molecular-glues-market-forecast
• Pneumoconiosis Market: https://www.delveinsight.com/report-store/pneumoconiosis-market
• Polypoidal Choroidal Vasculopathy Market: https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
• Sts Devices Market: https://www.delveinsight.com/report-store/sts-devices-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/ats-conference-coverage

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.